Search

  • HOME
  • Search
Original Article
431
Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors
Joongwon Choi, Tae Jin Kim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Minyong Kang, Seong Il Seo
Korean J Urol Oncol. 2019;17(3):150-159.   Published online December 27, 2019
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Case Report
398
Long-Lasting Antiandrogen Withdrawal Syndrome in Castration-Resistant Prostate Cancer: Three Cases With Complete Response
Sang Jin Kim, Jae Hyun Ryu, Yun Beom Kim, Tae Young Jung
Korean J Urol Oncol. 2018;16(1):38-41.   Published online April 27, 2018
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
Predictive Factors for Maximal Size Reduction of Renal Target Lesion in Patients with Metastatic Renal Cell Carcinoma Receiving Targeted Therapies
Sung Han Kim , In-Chang Cho , Sun Ho Kim , Jae Young Joung , Ho Kyung Seo , Kang Hyun Lee , Heong Dong Yuk , Jinsoo Chung
Korean J Urol Oncol. 2014;12(3):124-131.   Published online December 30, 2014
PDFPDF    
Review Article
Current Understanding of Bladder Immune Response to BCG Therapy
Byung Hoon Chi , In Ho Chang
Korean J Urol Oncol. 2014;12(1):16-22.   Published online April 30, 2014
PDFPDF    

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043



Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI